您要查找的是不是：
- Poor Peripheral Blood Stem Cell Mobilization or Poor Harvest ? 周边血干细胞驱动不良或是收集成效不佳?
- These include adipogenic, muscle, intraoral, dermal, and peripheral blood stem cells. 这当中包括成脂细胞，肌细胞，表皮细胞，外周血干细胞。
- Objective To study the factors that influence the mobilization of peripheral blood stem cells. 目的研究影响外周血干细胞的动员及采集因素。
- Three leukapheresis procedures (0, +1, +2 days) were performed by Baxter CS 3 000 plus blood cell separator to collect peripheral blood stem cells. 采用美国Baxter CS-3000plus血细胞分离机采集外周血干细胞,每位供者采集0,+1,+2d3次。
- Methods; Allogeneic peripheral blood stem cell non-myeloablative transplantation. 方法:异基因非清髓性外周血干细胞移植。
- Results were correlated to TL in CD34+ hematopoietic peripheral blood stem cells and progenitor cells obtained from the same individual patients. 将从同一组个体患者中获取的结果与外周血CD34+造血干细胞和祖细胞的端粒长度进行关联。
- Conclusion: Allogeneic peripheral blood stem cell non-myeloablative transplantation can be selectively used in the treatment of metastasis breast cancer. 结论:异基因非清髓性外周血干细胞移植可选择性地应用于晚期乳腺癌的治疗。
- Objective To study the effect of ABO -incompatibility on allogeneic peripheral blood stem cell transplantation(Allo-PBSCT) of HLA compatibility. 目的探讨ABO血型不合对HLA相合的异基因外周血干细胞移植(allogeneic peripheral bloodstem cell transplantation,Allo-PBSCT)的影响。
- Objective:To explore the treatment of pure red cell aplasia(PRCA)after ABO-incompatible alloge- neic peripheral blood stem cell transplantation. 目的：探讨ABO血型不合异基因外周血干细胞移植后纯红细胞再生障碍性贫血(PRCA)的治疗。
- Objective: To study the effect of allogeneic peripheral blood stem cell transplantation (PBSCT) with low dose pretreatment in chronic myelocytic leukemia (CML). 目的 探讨低预处理剂量异基因外周血造血干细胞移植 (allo -PBSCT)治疗慢性粒细胞白血病 (CML)的治疗效果。
- Objective To study the role of nonmyeloablative allogeneic peripheral blood stem cell transplantation (NAST) in the treatment of hematological diseases in elderly patients. 目的探讨非清髓异基因外周造血干细胞移植(NAST)在治疗高龄血液病中的作用。
- Objective To summarize the nursing experiences in the autologous peripheral blood stem cell transplantation (APBSCT) of patients with progressive multiple sclerosis (PMS). 目的总结进展型多发性硬化(PMS)患者行自体外周造血干细胞移植(APBSCT)治疗的护理经验。
- Objective To study the feasibility and efficacy of high dose chemotherapy with the support of autologous peripheral blood stem cell (APBSC) for patients. 目的研究在自体外周血干细胞支持下的高剂量化疗治疗实体瘤的疗效、可行性和安全性。
- Objective To study the psychological effect of nursing intervention on a patient's expecting to receive peripheral blood stem cell transplantation (PBSCT). 目的探讨护理干预对预行外周血造血干细胞移植患者焦虑心理的影响程度。
- Objective To observe the changes of peripheral blood stem cells and stem cell factor(SCF) in patients with acute myocardial infarction(AMI) and the relationship between AMI and stem cells and SCF in peripheral blood. 目的观察急性心肌梗死(AMI)患者外周血干细胞和干细胞因子(stem cell factor,SCF)的变化及两者的相关性。
- Methods:4 patients with hematological disease were mobilized with Cy+AraC+G-CSF before peripheral blood stem cells(PBSC) were collected. Peripheral blood stem cells transfusion were on 0 day and 3rd day after conditioning regimens. 方法:对4例血液肿瘤患者经化疗+G -CSF动员并采集外周血干细胞,预处理后分别于0、+ 3天回输外周血干细胞采集物,观察外周血ANC、BPC及移植相关并发症和血液制品支持治疗情况。
- Methods:Chimersim kinetic from T lymphocyte and myelocyte during allogenc peripheral blood stem cell transplantation in one patient with CML was analysied by FISH and cells cultur. The dosege of CsA and DLI was conditioned. 方法 :1例高龄慢粒白血病慢性期患者 ,在骨髓非清除性异基因外周血干细胞移植后 ,用细胞培养结合 FISH法动态监测髓细胞和 T淋巴细胞的嵌合状态 ,适时调整 Cs A剂量和进行 DL I治疗。
- High dose chemotherapy with peripheral blood stem cells transplantation (PBSCT) has been used worldwide in the treatment of patients with various hematological malignancies and other solid tumors. 高剂量化学治疗并血液 干细胞移植 之临床应用已有十年的历史,然而有关这方面的治疗在台湾仍鲜有报告。
- Objective:To study the therapeutic and effect of autologous peripheral blood stem cell transplantation (APBSCT) in combination with anti-CD20-monoclonal antibody (rituximab)on autoimmune hemolytic anemia (AIHA). 目的:探讨自体外周血干细胞移植(autologous peripheral blood stem cell transplantation,APBSCT)联合抗CD20单克隆抗体利妥昔单抗治疗自身免疫性溶血性贫血(autoimmune hemolytic anemia,AIHA)的疗效。
- In 26 CML patients received allogeneic peripheral blood stem cell transplantation (allo-PBSCT ) and 4 CML patients treated with imatinib, the expression of bcr-abl mRNA and DNA-PKcs protein was detected by RT-PCR and Western blot, respectively. 对26例接受同种异基因外周血干细胞移植(allo-PBSCT)及4例使用伊马替尼治疗的CML患者用RT-PCR、Western blot方法分别动态检测bcr-abl mRNA和DNA-PKcs蛋白表达水平;
